Organized by Alnylam, Ionis, HSCI, Nature, Nature Biotechnology and Nature Reviews Drug Discovery.
The 2025 conference brings together leading academics and industry professionals to explore developments and challenges in the rapidly evolving field of nucleic acid medicines. By uniting researchers from basic science, translational medicine, promising start-ups and biotechnology companies, the event aims to create a unique environment for meaningful dialogue and collaboration.
The conference will feature in-depth discussions on:
- Translational developments of basic nucleic acid biology
- Recent clinical successes using nucleic acid gene therapies
- Advancements in nucleic acid chemistry
The three-day program offers comprehensive coverage of applications of fundamental biology, a panel discussion and ample space to connect with editors, speakers and fellow attendees.